维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="LOANNIS A"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Synthesis and degradability of a novel aliphatic polyester based on L-lactide and sorbitol: 3 显示文摘	LOANNIS A ATSUYOSHI N ELENI P	1996	Polymer1996，37，4：	1
	2	Recent Advances in the Bioremediation of Arsenic - contaminated Groundwaters 显示文摘	Anastasios I Zouboulis loannis A Katsoyiannis	2005	Environment International2005，31，：	1
	3	Oral and cranio-maxillufacial surgery in Byzantium 显示文摘	MYLONAS A I ANDROUTSOS G I LOANNIS S	2014	Journal of cranio-maxillofacial surgery2014，42，15：	1
	4	Platelet activation in pregnancy-induced hypertension 显示文摘	loannis K Sunil K Eman A	2005	Thromb Res2005，116，1：	1
	5	A license plate-recognition algorithm forintelligent transportation system applications显示文摘	Nikolaos C loannis Anagnostopoulos A Loumos V	2006	IEEE Transactions on Intelligent Transportation Systems2006，7，3：	1
	6	Novel star-shaped polylactide with glycerol using stannous octoate or tetraphenyl tin as catalyst显示文摘	Atsuyishi Nakayama Norioki Kwasaki	1995	Polym1995，36，15：	1
	7	Novel star-shaped polylactide with glycerol using stannous octoate or tetraphenyl tin as catalyst显示文摘	LOANNIS A ATSUYISHI N NORIOKI K	1995	Polym1995，36，15：	1
	8	Sample pretreatment method for the determination of polychlorinated biphenyls in bird livers using ultrasonic extraction followed by headspace solid-phase microextraction and gas chromatography - mass spectrometry 显示文摘	Dimitra A Lambropoulou loannis K Konstantinou Triantafyllos A Albanls	2006	Journal of Chromatography A2006，1124，12：	1
	9	Real time enhanced random sampling of online social networks 显示文摘	GIANNIS H LOANNIS A	2014	Journal of Network and Computer Application~2014，41，1：	1
	10	Nonlinear re- sponse of deep immersed tunnel to strong seismic sha- king显示文摘	Loannis A Nikos G Vasileios D	2007	Journal of Geotechnieal and Geoenvironmen- tal Engineering2007，，：	1
	11	Theories, methods and current research on emotions in library and information science, information retrieval and human-computer interaction 显示文摘	Irene L loannis A	2011	Information Processing & Management2011，47，4：	1
	12	Nonlinear re- sponse of deep immersed tunnel to strong seismic sha- king 显示文摘	Loannis A Nikos G Vasileios D	2007	Journal of Geotechnieal and Geoenvironmen tal Engineering2007，133，：	1
	13	Efficiency and energy requirements for the transformation of organic micro- pollutants by ozone O3/H2O2 and UV/H2O2显示文摘	loannis A Katsoyiannis Silvio Canonica Urs von Gunten	2011	Water Research2011，45，：	1
	14	Semi-automatic object-based video segmentation with labeling of color segments显示文摘	Patras loannis Hendriks Emile A Lagendijk Reginald L	2003	Signal Processing: Image Communication2003，18，1：	1
	15	Eribulin for heavily pre-treated metastatic breast cancer patients显示文摘AIM: To discuss treatment with eribulin in clinical practice outside a clinical trial.METHODS: Archives of patients treated for metastatic breast cancer were reviewed and 21 patients treated with the new chemotherapeutic eribulin mesylate, a synthetic analog of a natural marine product, were identified. Information on patients' characteristics and treatment outcomes was extracted. Treatment with eribulin mesylate was initiated at the recommended dose of 1.4 mg/m2 on days 1 and 8 of a 21-day cycle in 17 patients and at a decreased dose of 1.1 mg/m2 on days 1 and 8 of a 21-day cycle in 4 patients due to comorbidities and frailty. Efficacy of the drug was evaluated using the revised Response Evaluation Criteria in Solid Tumors criteria. Progression-Free Survival and overall survival(OS) were calculated using the Kaplan-Meier method starting from the date of eribulin therapy initiation to the date of disease progression documentation or death, respectively.RESULTS: The median age of patients at the time of eribulin mesylate treatment was 53 years(range 34-75). Sixteen patients had estrogen receptor(ER) and/or partial response(PR) positive disease and 5 had ER/PR negative disease(all triple negative). Eight patients had received 2 or 3 previous lines of chemotherapyfor metastatic disease and 13 patients had received 4 or more lines of treatment. The median number of cycles of eribulin received was 3(range 1-16 years). All patients, except one, discontinued treatment due to progressive disease and one patient due to adverse effects. Six patients had a dose reduction due to side effects. All patients had progressed at the time of the report with a median time to progression of 3 mo(range 1 to 14 mo). Fifteen patients had died with a median OS of 7 mo(range 1-18 mo). Six patients were alive with a median follow-up of 13.5 mo(range 7 to 19 mo).CONCLUSION: This series of patients confirms the activity of eribulin in a heavily pre-treated metastatic breast cancer population consistent with phase Ⅱ and Ⅲ trials.	Antonia Digklia Loannis A Voutsadakis	2015	World Journal of Experimental Medicine2015，5，3：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费